loadpatents
Patent applications and USPTO patent grants for SEENISAMY; Jeyaprakashnarayanan.The latest application filed is for "indene derivatives useful in treating pain and inflammation".
Patent | Date |
---|---|
Indene Derivatives Useful In Treating Pain And Inflammation App 20220306645 - HARWIG; Curtis ;   et al. | 2022-09-29 |
Indene derivatives useful in treating pain and inflammation Grant 11,420,962 - Harwig , et al. August 23, 2 | 2022-08-23 |
Process for manufacturing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide App 20220251072 - Heinrich; Timo ;   et al. | 2022-08-11 |
Indene derivatives useful in treating pain and inflammation Grant 11,352,367 - Harwig , et al. June 7, 2 | 2022-06-07 |
Heteroaryl compounds as BTK inhibitors and uses thereof Grant 11,098,041 - Gaillard , et al. August 24, 2 | 2021-08-24 |
Indene Derivatives Useful In Treating Pain And Inflammation App 20210155615 - HARWIG; Curtis ;   et al. | 2021-05-27 |
Indene Derivatives Useful In Treating Pain And Inflammation App 20210032264 - HARWIG; Curtis ;   et al. | 2021-02-04 |
Hexadecahydro-1h-cyclopenta[a]phenanthrene Derivatives Useful In Treating Pain And Inflammation App 20210024571 - HARWIG; Curtis ;   et al. | 2021-01-28 |
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof App 20210000825 - Siddiqui-Jain; Adam ;   et al. | 2021-01-07 |
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof App 20190233417 - Gaillard; Pascale ;   et al. | 2019-08-01 |
Heteroaryl compounds as BTK inhibitors and uses thereof Grant 10,253,023 - Gaillard , et al. | 2019-04-09 |
Cyclic amides as MetAP-2 inhibitors Grant 10,093,623 - Heinrich , et al. October 9, 2 | 2018-10-09 |
Synthesis of a substituted indene derivative Grant 10,053,415 - Harwig , et al. August 21, 2 | 2018-08-21 |
Synthesis Of A Substituted Indene Derivative App 20180086691 - Harwig; Curtis ;   et al. | 2018-03-29 |
Synthesis Of A Substituted Indene Derivative App 20170204048 - Harwig; Curtis ;   et al. | 2017-07-20 |
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors Grant 9,688,702 - Swinnen , et al. June 27, 2 | 2017-06-27 |
Imidazopyrimidine derivatives Grant 9,617,266 - Hoelzemann , et al. April 11, 2 | 2017-04-11 |
Alpha hydroxy amides Grant 9,585,891 - Muzerelle , et al. March 7, 2 | 2017-03-07 |
Novel Quinoline Derivatives And Their Use In Neurodegenerative Diseases App 20160296509 - KARRA; Srinivasa R. ;   et al. | 2016-10-13 |
Quinoline derivatives and their use in neurodegenerative diseases Grant 9,399,623 - Karra , et al. July 26, 2 | 2016-07-26 |
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof App 20160096834 - GAILLARD; Pascale ;   et al. | 2016-04-07 |
Imidazopyrimidine Derivatives App 20160002242 - HOELZEMANN; Guenter ;   et al. | 2016-01-07 |
Novel Quinoline Derivatives And Their Use In Neurodegenerative Diseases App 20150353497 - KARRA; Srinivasa R. ;   et al. | 2015-12-10 |
Alpha Hydroxy Amides App 20150250792 - Muzerelle; Mathilde ;   et al. | 2015-09-10 |
Cyclic Amides As Metap-2 Inhibitors App 20150031670 - Heinrich; Timo ;   et al. | 2015-01-29 |
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors App 20140364396 - Swinnen; Dominique ;   et al. | 2014-12-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.